Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-24 1:43 pm Purchase | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,365,472 19.99% | 167,553 (+7.62%) | View |
| 2023-11-21 5:24 pm Sale | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 1,987,702 9.99% | -28,058 (-1.39%) | View |
| 2023-11-14 5:18 pm Sale | 13D | BeiGene, Ltd. BGNE | BAKER BROS. ADVISORS LP | 138,678,037 13% | -14,300,000 (-9.35%) | View |
| 2023-11-13 4:22 pm Purchase | 13G | Cerus Corporation CERS | BAKER BROS. ADVISORS LP | 19,101,876 10.5% | 3,014,454 (+18.74%) | View |
| 2023-10-10 4:42 pm Sale | 13D | Neoleukin Therapeutics, Inc. NLTX | BAKER BROS. ADVISORS LP | 1,894,669 19.99% | -7,577,429 (-80.00%) | View |
| 2023-10-05 4:36 pm Purchase | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 2,015,760 9.99% | 470,647 (+30.46%) | View |
| 2023-08-17 5:12 pm Sale | 13D | Neoleukin Therapeutics, Inc. NLTX | BAKER BROS. ADVISORS LP | 9,472,098 19.99% | -570,979 (-5.69%) | View |
| 2023-08-10 4:42 pm Sale | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 14,604,391 2.2% | -54,754,968 (-78.94%) | View |
| 2023-08-10 4:39 pm Sale | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 0 0% | -1,345,192 (Position Closed) | View |
| 2023-08-08 5:16 pm Unchanged | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.4% | 0 (Unchanged) | View |
| 2023-07-19 5:28 pm Purchase | 13D | Neoleukin Therapeutics, Inc. NLTX | BAKER BROS. ADVISORS LP | 10,043,077 19.99% | 5,813,250 (+137.43%) | View |
| 2023-06-28 5:01 pm Purchase | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,277,567 9.99% | 107,673 (+3.40%) | View |
| 2023-06-16 7:18 pm Unchanged | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.4% | 0 (Unchanged) | View |
| 2023-06-12 4:37 pm Sale | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 1,345,192 8% | -25,643,706 (-95.02%) | View |
| 2023-06-02 4:06 pm Purchase | 13D | TScan Therapeutics, Inc. TCRX | BAKER BROS. ADVISORS LP | 2,793,938 6.5% | 9,146 (+0.33%) | View |
| 2023-05-24 5:11 pm Purchase | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 43,227,599 26.5% | 920,810 (+2.18%) | View |
| 2023-05-24 4:31 pm Purchase | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,219,080 19.5% | 92,663 (+0.92%) | View |
| 2023-05-05 4:33 pm Sale | 13D | BeiGene, Ltd. BGNE | BAKER BROS. ADVISORS LP | 152,978,037 13% | -1,337,453 (-0.87%) | View |
| 2023-05-05 4:24 pm Sale | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,197,919 19.99% | -293,325 (-11.77%) | View |
| 2023-05-03 4:15 pm Sale | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 45,074,469 24% | -2,159,182 (-4.57%) | View |